Spruce Biosciences SPRB
NASDAQ SPRB
$45.01 +0.24 (+0.54%)
As of: Oct 2, 2026 · 1:01 PM EDT

Spruce Biosciences (SPRB) Long-Term Investments (2021 - 2022)

Updated

Spruce Biosciences (SPRB) reported Long-Term Investments of $5.81 million for Q2 2022, down 80.5% from $29.77 million a year earlier and down 67.0% from the prior quarter.

Analysis

Spruce Biosciences (SPRB) Long-Term Investments (2021 - 2022) Analysis & Trends

At the end of FY2021, Spruce Biosciences posted Long-Term Investments of $32.46 million.

  • Per Business Quant data, the three quarters before Q2 2022 came in at $17.6 million (Q1 2022), $32.46 million (Q4 2021) and $38.98 million (Q3 2021).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Long-Term Investments (Qtr)
1 Johnson & Johnson 638.12 Bn 556.64 Bn 17.26 Bn -
2 AbbVie 462.60 Bn 435.75 Bn 12.70 Bn 266.00 Mn
3 Merck 358.70 Bn 313.13 Bn 12.21 Bn 1.22 Bn
4 Novartis Ag 272.16 Bn 228.03 Bn 11.24 Bn 69.00 Mn
5 Astrazeneca 250.36 Bn 223.92 Bn 12.86 Bn 2.62 Bn
6 Amgen 227.87 Bn 183.27 Bn 7.24 Bn -
7 Gilead Sciences 184.97 Bn 159.08 Bn 6.22 Bn -
8 Pfizer 162.61 Bn 109.56 Bn 10.94 Bn 1.56 Bn
9 Vertex Pharmaceuticals 132.45 Bn 104.46 Bn 2.84 Bn 5.79 Bn
10 Spruce Biosciences 133.73 Mn 133.73 Mn - -
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2022 5.81 Mn
Mar 31, 2022 17.60 Mn
Dec 31, 2021 32.46 Mn
Sep 30, 2021 38.98 Mn
Jun 30, 2021 29.77 Mn
API Access

Spruce Biosciences Long-Term Investments API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=long-term-investments&ticker=SPRB&period=max&api_key=YOUR_API_KEY